AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-3565595_ITM" title="Facts and information about NSAID, proton pump combo.(Products)">NSAID, proton pump combo.(Products)</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
NSAID, proton pump combo.(Products)
Prevacid NapraPAC (lansoprazole delayed-release capsules and naproxen tablets kit) is now approved for reduction of NSAID-associated gastric ulcers in patients with a history of a documented gastric ulcer who require the use of an NSAID for the treatment of the signs and symptoms of ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- PREVACID(R) (lansoprazole) is First Proton Pump Inhibitor Approved for Healing...
- Press release article from: PR Newswire December 6, 2000 700+ words
...Important for Chronic NSAID Users Who Suffer From...PRNewswire/ -- TAP Pharmaceutical Products Inc. announced today...risk reduction of NSAID-associated gastric...effectively heals NSAID-associated gastric...com . About TAP Pharmaceutical Products Inc. TAP ...
- FDA COMMITTEE RECOMMENDS CHANGES IN NSAID LABELING; CALL ISSUED FOR EDUCATION,...
- Press release article from: PR Newswire October 12, 1995 700+ words
...FDA hearing indicate that NSAID-induced GI damage accounts...rates are even higher among NSAID users with risk factors...misoprostol along with their NSAID and the remainder received...manufactures and markets pharmaceutical products and other healthcare solutions...
- AlphaRx and Proprius Pharmaceuticals Announce License Agreement for...
- Press release article from: PR Newswire April 11, 2006 700+ words
...right formulation, a topical NSAID offers the potential of matching...the potential of our topical NSAID drugs," said Michael Lee...development and commercialization of pharmaceutical products, and has previously been...TM) is AlphaRx's topical NSAID (Non-Steroidal Anti-inflammatory...
- POZEN Presents Data on PN 100 Combination Product--Designed to Help Prevent...
- Press release article from: Business Wire November 2, 2005 700+ words
...anti-inflammatory drug (NSAID). These drug candidates...complications in patients who use NSAID therapy for arthritis and...PPI) lansoprazole and the NSAID naproxen, both of which have...primarily on the development of pharmaceutical products for the treatment of migraine...
- STUDY REVEALS WHICH NSAID USERS ARE MOST AT RISK OF SERIOUS GI DAMAGE;...
- Press release article from: PR Newswire August 14, 1995 700+ words
...present during a six-month period of NSAID use, the risk of life-threatening...even higher with the longer periods of NSAID use that many arthritis patients require...develops, manufactures and markets pharmaceutical products and other healthcare solutions worldwide...
- SYNTEX RECEIVES FDA CLEARANCE FOR KETOROLAC OPHTHALMIC; ALLERGAN TO MARKET...
- Press release article from: PR Newswire November 11, 1992 700+ words
...CLEARANCE FOR KETOROLAC OPHTHALMIC; ALLERGAN TO MARKET FIRST NSAID FOR SEASONAL ALLERGIC CONJUNCTIVITIS PALO ALTO, Calif...Syntex also develops, manufactures and markets animal pharmaceutical products and medical diagnostic systems. Allergan Inc., a global...
- Allergan Announces FDA Approval of ACULAR LS Ophthalmic Solution; The New...
- Press release article from: Business Wire June 2, 2003 700+ words
...Irvine, California, is a technology-driven, global health care company providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care, neuromodulator and skin care markets...
- POZEN Reports First Quarter 2005 Results; Trexima NDA Scheduled for 3Q 2005;...
- Press release article from: Business Wire April 28, 2005 700+ words
...or patient convenience. Since its inception, POZEN has focused its efforts primarily on the development of pharmaceutical products for the treatment of migraine. POZEN is also exploring the development of product candidates in other pain...